`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`PROLLENIUM US INC.,
`Petitioner,
`v.
`ALLERGAN INDUSTRIE, SAS,
`Patent Owner.
`_____________
`IPR2019-01505, Patent 8,450,475 B2
`IPR2019-01506, Patent 8,357,795 B2
`IPR2019-01508, Patent 9,238,013 B2
`IPR2019-01509, Patent 9,358,322 B2
`IPR2019-01617, Patent 8,822,676 B2
`IPR2019-01632, Patent 8,357,795 B2
`IPR2020-00084, Patent 9,089,519 B2
`_____________
`
`JOINT STIPULATION TO MODIFY DUE DATE 1
`IN SCHEDULING ORDER1
`
`
`1 Authorization for the use of a joint caption page was received on April 27, 2020.
`Neither party opposes the use of a joint caption page. An identical paper has been
`filed in each case recited in the consolidated caption.
`
`
`
`IPR2019-01505, Patent 8,450,475 B2; IPR2019-01506, Patent 8,357,795 B2;
`IPR2019-01508, Patent 9,238,013 B2; IPR2019-01509, Patent 9,358,322 B2;
`IPR2019-01617, Patent 8,822,676 B2; IPR2019-01632, Patent 8,357,795 B2;
`IPR2020-00084, Patent 9,089,519 B2
`
`Prollenium US Inc. (“Petitioner”) and Allergan Industrie, SAS (“Patent
`
`Owner”), by and through their respective counsel of record, hereby stipulate as
`
`follows:
`
`On April 13, 2020, the Scheduling Order in the Inter Partes Review of U.S.
`
`Patent No. 8,450,475 (IPR2019-01505), U.S. Patent No. 8,357,795 (IPR2019-
`
`01506), U.S. Patent No. 9,238,013 (IPR2019-01508), U.S. Patent No. 9,358,322
`
`(IPR2019-01509), U.S. Patent No. 8,822,676 (IPR2019-01617), U.S. Patent No.
`
`8,357,795 (IPR2019-01632), and U.S. Patent No. 9,089,519 (IPR2020-00084) set
`
`forth “due dates for the parties to take action in this trial,” and further stated that
`
`the “parties may stipulate different dates for DUE DATES 1, 2, 5, and 6, as well as
`
`the portion of DUE DATE 3 related to Patent Owner’s sur-reply (earlier or later,
`
`but no later than DUE DATE 7).” Id. at 7.
`
`Patent Owner and Petitioner hereby stipulate to modify DUE DATE 1 as
`
`follows:
`
`DUE DATE 1:
`
`September 1, 2020
`
`This stipulation does not affect or otherwise modify DUE DATES 2–8 in the
`
`Scheduling Order.
`
`
`
`
`
`
`
`1
`
`
`
`IPR2019-01505, Patent 8,450,475 B2; IPR2019-01506, Patent 8,357,795 B2;
`IPR2019-01508, Patent 9,238,013 B2; IPR2019-01509, Patent 9,358,322 B2;
`IPR2019-01617, Patent 8,822,676 B2; IPR2019-01632, Patent 8,357,795 B2;
`IPR2020-00084, Patent 9,089,519 B2
`
`
`
`Date: August 19, 2020
`
`
`
`Date: August 19, 2020
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`/Warren J. Thomas/
`Warren J. Thomas
`Reg. No. 70,581
`Petitioner, Prollenium US Inc.
`
`/Anthony M. Insogna/
`Anthony M. Insogna
`Reg. No. 35,203
`Patent Owner, Allergan Industrie, SAS
`
`2
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Petitioner a true and correct copy of this Joint Stipulation to Modify
`
`Due Date 1 in Scheduling Order by electronic means at the following address of
`
`record:
`
`mcc.prollenium.ipr@mcciplaw.com
`
`Dated: August 19, 2020
`
`
`/Anthony M. Insogna/
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel.: (858) 314-1200
`Fax.: (844) 345-3178
`
`Attorney for Patent Owner
`
`
`
`
`
`
`
`
`
`